Şalazyon Tedavisinde Triamsinolon Asetonid Enjeksiyonunun Etkinliği

Yıl 2020, Cilt: 12 Sayı: 3, 66 - 71, 15.04.2021

Bilge Eraydın Can Gedik

Öz

Amaç: Şalazyon tedavisinde lezyon içine yapılan triamsinolon asetonid enjeksiyonunun etkinliğini ve güvenilirliğini değerlendirmek.
Gereç ve Yöntemler: En az bir ay süren konservatif ve medikal tedaviye yanıt vermeyen orta (3-7 mm) ve büyük boyutlarda (>7 mm) primer şalazyonu olan 20 göz retrospektif olarak incelendi. Lezyonların içine 0.1-0.2 mL triamsinolon asetonid (40 mg/mL) enjekte edilerek, enjeksiyondan önce ve enjeksiyondan sonraki ikinci hafta, birinci ay, ikinci ay, üçüncü ay lezyon boyutları ve komplikasyonlar kaydedildi.
Bulgular: Enjeksiyon sonrası ikinci hafta kontrollerinde 17 (%85) hastada lezyon boyutunda gerileme izlenmiş olup 12 (%60) hastada birinci ayda tam rezolüsyon görüldü. İkinci ay kontrolerinde toplamda 18 hastada tam rezolüsyon, üçüncü ay kontolleri devam eden 2 hastada ise lezyon boyutlarında küçülme mevcuttu. Hastaların 2’sinde enjeksiyon sonrasında cilt depigmentasyonu gözlenmiş olup üçüncü ay kontrolleri sonunda depigmentasyon saptanmadı ve gözlenen başka bir komplikasyon olmadı.
Sonuç: İzlenen yüksek başarı oranları neticesinde konservatif ve medikal tedaviye yanıtsız şalazyon hastalarında lezyon içine uygulanan triamsinolon asetonid enjeksiyonu, cerrahi tedavi öncesi bir seçenek olarak düşünülebilir.

Anahtar Kelimeler

Şalazyon, Triamsinolon asetonid, cerrahi tedavi

Efficiency of Triamcinolone Acetonide Injection in the Treatment of Chalazion

Öz

Purpose: To evaluate the efficacy and safety of triamcinolone acetonide injection into the lesion in the treatment of chalazion.
Materials and Methods: Twenty eyes with medium (3-7 mm) and large sizes (> 7 mm) primary chalazion that did not respond to conservative and medical treatment lasting at least one month were retrospectively analyzed. Lesion sizes and complications were recorded by injecting 0.1-0.2 mL triamcinolone acetonide (40 mg / mL) into the lesions, and the second week before and after the injection, first month, second month, third month after injection.
Results: In the second week post-injection, 17 (85%) patients had a decrease in lesion size, and 12 (60%) patients had complete resolution in the first month. In the second month controls, a total of 18 patients had complete resolution, and 2 patients who continued their third month control had a reduction in lesion size. In 2 of the patients, skin hypopigmentation was observed after injection, and depigmentation was not detected at the end of the 3rd month controls and there were no other complications observed.
Conclusion: As a result of the high success rates observed, triamcinolone acetonide injection may be considered as a pre-surgical option.

Anahtar Kelimeler

Chalazion, Triamcinolone acetonide

Kaynakça

• 1. Jin KW, Shin YJ, Hyon JY. Effects of chalazia on corneal astigmatism: Large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism. BMC Ophthalmol 2017;17(1):36.
• 2. Dua HS, Nilawar DV. Nonsurgical therapy of chalazion [letter]. Am J Ophthalmol 1982;94:424–5.
• 3. Garrett GW, Gillespie ME, Mannix BC. Adrenocorticosteroid injection vs. conservative therapy in the treatment of chalazia. Ann Ophthalmol 1988;20:196–8.
• 4. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology 1980;87:218–21.
• 5. Aycinena AR, Achiron A, Paul M, Burgansky-Eliash Z. Incision and Curettage Versus Steroid Injection for the Treatment of Chalazia: A Meta-Analysis. Ophthalmic Plast Reconstr Surg 2016;32(3):220-4.
• 6. Unal M. Chalazion treatment. Orbit 2008;27(6):397–398.
• 7. Ben Simon GJ, Rosen N, Rosner M, Spierer A. Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia: a prospective, randomized study. Am J Ophthalmol 2011;151(4):714–718.
• 8. Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. Clin Exp Ophthalmol 2007;35(8):706–712.
• 9. Khurana A.K., Ahluwalia B.K., Rajan C. Chalazion Therapy. Intralesional steroids versus incision and curettage. Acta Ophthalmol 1988;66(3):352–354.
• 10. Thomas EL, Laborde RP. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion. Ophthalmology 1986;93(3):405-7.
• 11. Ağci A, Palamar M, Eğrilmez S, Sahbazov C, Ozbek SS. Anterior segment ischemia and retinochoroidal vascular occlusion after intralesional steroid injection. Ophthal Plast Reconstr Surg 2008;24(1):55-7.
• 12. Procope JA, Kidwell ED Jr. Delayed postoperative hemorrhage complicating chalazion surgery. J Natl Med Assoc 1994;86(11):865-6.
• 13. Cohen BZ, Tripathi RC. Eyelid depigmentation after intralesional injection of a fluorinated corticosteroid for chalazion. Am J Ophthalmol 1979;88(2):269-70.
• 14. Kim E, Yu S, Jeong B, Lee K, Mun H. The Effects of intralesional steroid injection for chalazion according to the concentrations of triamcinolone acetonide. J Korean Ophthalmol Soc 2013;54(3):396–400.
• 15. Cosar CB, Rapuano CJ, Cohen EJ, Laibson PR. Chalazion as a cause of decreased vision after LASIK. Cornea 2001;20(8):890-2.
• 16. Mohan K, Dhir SP, Munjal VP, Jain IS. The use of intralesional steroids in the treatment of chalazion. Ann Ophthalmol 1986;18:158 – 60.